Hope for Katwijk Disease Patients: Medicine Test
- LEIDEN, Netherlands – A new examination offers a glimmer of hope for individuals affected by 'Katwijk disease,' a genetic disorder known to cause brain bleeds and premature death.
- Sanne van Rijn, a patient representative, expressed her enthusiasm, stating, "It feels like a huge victory."
- in the 1960s, a neurosurgeon in Leiden observed a high incidence of brain bleeds among residents of Katwijk, a coastal town in the Netherlands.
Hope Emerges for ‘Katwijk disease’ Sufferers as Research Begins
LEIDEN, Netherlands – A new examination offers a glimmer of hope for individuals affected by ‘Katwijk disease,’ a genetic disorder known to cause brain bleeds and premature death. Researchers at the Leiden University Medical Center (LUMC) have initiated a study focusing on a potential treatment to inhibit the progression of the disease, possibly delaying the onset of brain bleeds.
Sanne van Rijn, a patient representative, expressed her enthusiasm, stating, “It feels like a huge victory.”
The Origins of Katwijk disease
in the 1960s, a neurosurgeon in Leiden observed a high incidence of brain bleeds among residents of Katwijk, a coastal town in the Netherlands. Collaborating with a local general practitioner, the neurosurgeon identified a pattern indicative of an autosomal dominant genetic inheritance.This means individuals have a 50% chance of inheriting the affected gene from their parents.
Subsequent research led to the progress of blood tests to identify carriers of the gene. The disease’s name, ’Katwijk disease,’ stems from the disproportionate number of individuals with the genetic abnormality who reside in or originate from Katwijk. researchers emphasize that the disease is not a result of inbreeding but traces back to a single individual in Katwijk who initially acquired the gene mutation.
Current Reality: No cure
Currently, there is no cure for Katwijk disease.Individuals who test positive for the gene mutation face the grim reality of an almost certain brain hemorrhage during their lifetime.

Sanne van Rijn, 36, whose mother carries the gene abnormality, shared her experience. Her mother, now 65, has already experienced multiple brain bleeds and suffers from epilepsy, a relatively advanced age for someone with the condition.
A Shift in Perspective
“We actually had no hope for a treatment for a long time,” van Rijn told RTL News. The current research offers a renewed sense of optimism.While the potential therapy is not a cure, it aims to delay the onset of symptoms, improving the quality of life for those affected. Van Rijn acknowledges that this may be a disappointment for some, but views the possibility of slowing down the disease’s progression as a meaningful positive step.
Understanding the Disease
Radiologist Mark van buchem of the LUMC, a researcher involved in the study, explained that Katwijk disease, also known as Dutch-type cerebral amyloid angiopathy (CAA), affects the blood vessels in the brain. In individuals with the gene mutation, an abnormal protein called Amyloid-Beta accumulates in the small blood vessels, weakening the vascular walls and increasing the risk of brain bleeds, epilepsy, and dementia.
Neurologist Ellis van Etten of the LUMC noted that symptoms typically manifest around age 50, frequently enough triggered by a brain hemorrhage. These symptoms can include sudden neurological deficits, speech difficulties, vision problems, or paralysis.
The Broader Implications
While the specific gene mutation associated with katwijk disease is rare globally, a similar condition, CAA, is more common. Although CAA also involves amyloid-beta protein accumulation in brain blood vessels leading to brain bleeds, it is not linked to a specific gene abnormality and can affect anyone. Diagnosing CAA in living patients is often challenging.
the unique genetic clarity of Katwijk disease makes individuals from Katwijk invaluable participants in the new research.”the key to the solution of a worldwide problem lies in Katwijk,” said researcher Van Buchem.
Living with Uncertainty
Sanne van Rijn remains uncertain about her own gene status.”It would have no added value for me now to know my mutation status,” she stated. With the new investigation underway, she continues to live life to the fullest, pursuing her goals as if she carries the mutation. “And if I don’t appear to be a gene carrier, I have bonus years.”
Hope Emerges for ‘Katwijk Disease’: Your Questions Answered
What is Katwijk disease?
katwijk disease is a genetic disorder that leads to brain bleeds and premature death, primarily affecting individuals from the coastal town of Katwijk in the netherlands. Researchers at Leiden University Medical Center (LUMC) are currently studying potential treatments to slow the disease’s progression.
What are the origins of Katwijk disease?
The disease was first recognized in the 1960s by a neurosurgeon in Leiden who observed an unusually high number of brain bleeds among residents of Katwijk. Subsequent research revealed an autosomal dominant genetic inheritance pattern, meaning a person with the gene has a 50% chance of passing it on to their children. The disease is not a result of inbreeding but traces back to a single individual in Katwijk who originally acquired the gene mutation.
Is there a cure for Katwijk disease?
No, there is currently no cure for Katwijk disease. individuals who test positive for the gene mutation face a high risk of brain hemorrhage at some point in their lives.
What are the symptoms of katwijk disease?
Symptoms typically manifest around age 50, frequently enough triggered by a brain hemorrhage. These can include:
- Sudden neurological deficits
- speech difficulties
- vision problems
- Paralysis
What is the focus of the new research?
The new research at LUMC is focused on a potential treatment to inhibit the progression of the disease, possibly delaying the onset of brain bleeds. While not a cure, the therapy aims to improve the quality of life for those affected by slowing down the disease’s advance.
How dose Katwijk disease effect the brain?
Katwijk disease, also known as Dutch-type cerebral amyloid angiopathy (CAA), affects the blood vessels in the brain.The gene mutation causes an abnormal protein called Amyloid-Beta to accumulate in small blood vessels, weakening the vascular walls. This increases the risk of brain bleeds, epilepsy, and dementia.
What is the difference between Katwijk disease and Cerebral Amyloid Angiopathy (CAA)?
While both Katwijk disease and CAA involve amyloid-beta protein accumulation in brain blood vessels, leading to brain bleeds, they differ in two key ways:
- Genetic Link: Katwijk disease is linked to a specific gene mutation and is most prevalent in katwijk, Netherlands. CAA is more common but is not linked to a specific gene abnormality and can affect anyone.
- Diagnosis: Diagnosing CAA in living patients is often challenging.
Why are individuals with Katwijk disease critically important for research?
The unique genetic clarity of katwijk disease makes individuals from Katwijk invaluable participants in the new research.It allows researchers to focus on a single, known genetic cause, perhaps providing insights into a broader problem.As researcher Van Buchem stated, “the key to the solution of a worldwide problem lies in katwijk.”
How does Katwijk disease affect those who live with it?
People with Katwijk disease live with the constant knowledge of the almost certain risk of a brain hemorrhage. Sanne van Rijn, whose mother has the disease, shared that her mother has already experienced multiple brain bleeds and suffers from epilepsy.Despite this reality,the new research offers a renewed sense of hope,even though it is indeed currently is not a cure.
What does the future hold for people with Katwijk disease?
The research offers a ray of hope. While the potential therapy isn’t a cure, the goal is to delay the onset of symptoms and improve the quality of life for those living with the disease. Van Rijn views the possibility of slowing down the disease as a meaningful, positive step.
What are the implications of the research for those who may have the gene mutation?
The new research, while not offering a cure, represents a significant step in managing the disease. It provides hope for:
- Slowing down the progression of Katwijk disease.
- Potentially improving the quality of life for those affected.
How does uncertainty about gene status impact those whose families are affected by the disease?
Individuals like Sanne van Rijn live with uncertainty, choosing to live their lives to the fullest without knowing their own gene status.In her case, she stated, “it would have no added value for me now to know my mutation status.” This perspective emphasizes the focus on a proactive and optimistic approach to life, embracing the possibilities.
Key Differences Between Katwijk Disease and Cerebral Amyloid Angiopathy (CAA)
| Feature | Katwijk Disease | Cerebral Amyloid Angiopathy (CAA) |
|---|---|---|
| Genetic Basis | Specific gene mutation | Not linked to a specific gene abnormality |
| Prevalence | Rare globally, primarily in Katwijk | More common |
| Protein accumulation | Amyloid-Beta accumulation in brain blood vessels | Amyloid-Beta accumulation in brain blood vessels |
| Diagnosis | Easier due to specific genetic clarity | Often challenging |
